Epic Pharma, LLC has obtained FDA approval for ANDA 203863 to manufacture hydrocodone bitartrate and acetaminophen, broadening the generic availability of this widely prescribed painkiller. This commercial launch is expected to intensify competition against branded opioid formulations and drive price reduction in the analgesic market.